AMD 2022 Jul: AREDS2 Long-Term Outcomes: Lutein, Zeaxanthin, and AMD Progression

from Eye Research Deep Dive: Doctopus the Octometrist · host Dr Michael Nelson, OD FAAO

AREDS2 Long-Term Outcomes: Lutein, Zeaxanthin, and AMD ProgressionChew EY, Clemons TE, Agrón E, Domalpally A, Keenan TDL, Vitale S, Weber C, Smith DC, Christen W; AREDS2 Research Group. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28. JAMA Ophthalmol. 2022 Jul 1;140(7):692-698. doi: 10.1001/jamaophthalmol.2022.1640. PMID: 35653117; PMCID: PMC9164119.https://pmc.ncbi.nlm.nih.gov/articles/pmid/35653117/

Episode metadata supplied by the publisher feed · Published Nov 18, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

AMD 2022 Jul: AREDS2 Long-Term Outcomes: Lutein, Zeaxanthin, and AMD Progression

0:00 9:27

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Eye Research Deep Dive: Doctopus the Octometrist?

This episode is 9 minutes long.

When was this Eye Research Deep Dive: Doctopus the Octometrist episode published?

This episode was published on November 18, 2025.

Can I download this Eye Research Deep Dive: Doctopus the Octometrist episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!